ES487046A1 - Procedimiento de preparacion de proteoglicanos membranarios bacterianos purificados - Google Patents

Procedimiento de preparacion de proteoglicanos membranarios bacterianos purificados

Info

Publication number
ES487046A1
ES487046A1 ES487046A ES487046A ES487046A1 ES 487046 A1 ES487046 A1 ES 487046A1 ES 487046 A ES487046 A ES 487046A ES 487046 A ES487046 A ES 487046A ES 487046 A1 ES487046 A1 ES 487046A1
Authority
ES
Spain
Prior art keywords
proteoglycans
preparation
procedure
purified bacterial
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES487046A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of ES487046A1 publication Critical patent/ES487046A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/852—Klebsiella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/88—Serratia
    • Y10S435/881—Serratia marcescens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Procedimiento de preparación de proteglicanos membranarios bacterianos purificados, caracterizado porque comprende por lo menos una etapa de tratamiento de los proteoglicanos brutos en medio acuoso por una base o un hipobromito seguida por la eliminación del exceso de reactivo y del residuo insoluble, halládonse los proteglicanos purificados en solución acuosa.
ES487046A 1978-12-19 1979-12-19 Procedimiento de preparacion de proteoglicanos membranarios bacterianos purificados Expired ES487046A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7835649A FR2444464A1 (fr) 1978-12-19 1978-12-19 Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant

Publications (1)

Publication Number Publication Date
ES487046A1 true ES487046A1 (es) 1980-09-16

Family

ID=9216288

Family Applications (1)

Application Number Title Priority Date Filing Date
ES487046A Expired ES487046A1 (es) 1978-12-19 1979-12-19 Procedimiento de preparacion de proteoglicanos membranarios bacterianos purificados

Country Status (13)

Country Link
US (2) US4297272A (es)
EP (1) EP0013851B1 (es)
JP (1) JPS5585525A (es)
AR (1) AR223690A1 (es)
AT (1) ATE1249T1 (es)
AU (1) AU532755B2 (es)
CA (1) CA1139302A (es)
DE (1) DE2963201D1 (es)
ES (1) ES487046A1 (es)
FR (1) FR2444464A1 (es)
MX (1) MX7557E (es)
PT (1) PT70610A (es)
ZA (1) ZA796661B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540136A1 (fr) * 1983-01-28 1984-08-03 Roussel Uclaf Nouveau procede de preparation d'acylglycoproteines immunostimulantes extraites de klebsiella pneumoniae, compositions pharmaceutiques et procede de lutte contre les maladies allergiques
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4870053A (en) * 1980-09-19 1989-09-26 Roussel Uclaf Novel compositions and processes
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
JPH0662431B2 (ja) * 1984-12-14 1994-08-17 ライオン株式会社 歯周炎予防用経口ワクチン
JPS61151128A (ja) * 1984-12-24 1986-07-09 Advance Res & Dev Co Ltd コレステロ−ル低下活性ｒｎａ画分
JPS625991A (ja) * 1985-07-03 1987-01-12 Advance Res & Dev Co Ltd コレステロ−ル乃至トリグリセリド低下活性ｒｎａ画分
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
FR2596064B1 (fr) * 1986-03-18 1990-02-02 Pf Medicament Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
CA2156859A1 (en) * 1993-02-24 1994-09-01 Sherwood L. Gorbach Method of enhancing immune response to oral vaccines
FR2703252B1 (fr) * 1993-03-31 1996-09-06 Fernand Narbey Torossian Complexe immunomodulateur anti SIDA.
JP3814290B2 (ja) * 1993-12-09 2006-08-23 エスクナー，ハインリッヒ 抗原用のアジュバントおよびその製法ならびに用途
US6309642B1 (en) 1997-04-28 2001-10-30 The Research And Development Institute, Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
US6488929B2 (en) 1994-05-23 2002-12-03 Montana State University Candida albicans phosphomannan complex as a vaccine
WO1995031998A1 (en) * 1994-05-23 1995-11-30 The Research & Development Institute, Inc. Candida albicans adhesin as a vaccine
US20030072775A1 (en) * 1997-04-28 2003-04-17 The Research And Development Institute Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
FR2790961B1 (fr) * 1999-03-17 2001-06-22 Fabre Pierre Sante Utilisation d'une composition comprenant des proteoglycanes de klebsiella pneumoniae, et des ribosomes ou des arn ribosomaux bacteriens pour le traitement et/ou la prevention des maladies parodontales
RU2401839C2 (ru) * 2006-02-14 2010-10-20 Кусиро Индастриал Текнолоджи Сентер Способ получения протеогликана
US8857126B2 (en) 2011-08-15 2014-10-14 Valinge Flooring Technology Ab Mechanical locking system for floor panels
JP7070883B2 (ja) * 2017-03-08 2022-05-18 地方独立行政法人青森県産業技術センター ヒアルロン酸産生能が改善したプロテオグリカン
JP2022520999A (ja) * 2019-02-22 2022-04-04 エヴェロ バイオサイエンシズ，インコーポレーテッド 細菌の膜調製物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1300714A (fr) * 1959-11-13 1962-08-10 Pfizer & Co C Perfectionnements apportés aux procédés pour la production de lipopolysaccharides
US3408440A (en) * 1966-09-26 1968-10-29 Procter & Gamble Method of preparing substantially cell-free somatic antigens
US3855197A (en) * 1969-05-20 1974-12-17 Cassenne Lab Sa Glycoproteins extracted from microorganisms
FR2160326B1 (es) * 1971-11-19 1975-02-07 Anvar
JPS49420A (es) * 1972-04-18 1974-01-05
US4001395A (en) * 1972-06-20 1977-01-04 Agence Nationale De Valorisation De La Recherche (Anvar) Hydrosoluble extracts of mycobacteria
NL7308450A (es) * 1972-06-20 1973-12-27
US4069314A (en) * 1973-02-23 1978-01-17 Christopher Adlam Glycopeptide extract
FR2253499B1 (es) 1973-12-10 1977-11-04 Fabre Sa Pierre
DE2403733A1 (de) * 1974-01-26 1975-08-14 Hoechst Ag Neue lipopolysaccharide und verfahren zu ihrer herstellung
AR207237A1 (es) * 1974-02-25 1976-09-22 Thomas A Procedimiento para obtener extractos biologicos estables liofilizados solubles constituidos por complejos proteicos termorresistentes
FR2261755A1 (en) * 1974-02-25 1975-09-19 Thomas Andre Glyco protein and mucopolysaccharides extraction - from naturally occuring materials fr use in cosmetics
FR2268531B1 (es) * 1974-04-25 1978-07-21 Anvar
FR2273067A1 (en) * 1974-05-31 1975-12-26 Anvar Bacterial cell treatment - by autolysis in absence of added enzymes
FR2305990A1 (fr) 1975-04-02 1976-10-29 Fabre Sa Pierre Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens
US4096073A (en) * 1975-06-30 1978-06-20 Phillips Petroleum Company Microbial viscosifiers
FR2316964A1 (fr) * 1975-07-11 1977-02-04 Pasteur Institut Medicament contenant, a titre de principe actif, un produit a base de polysaccharides, notamment obtenu a partir de lipopolysaccharides bacteriens
FR2321896A1 (fr) * 1975-08-29 1977-03-25 Anvar Agents adjuvants immunologiques actifs en solution aqueuse
FR2351664A2 (fr) * 1976-05-19 1977-12-16 Choay Sa Fraction inductrice d'une resistance aux infections bacteriennes, extractible de bacteries notamment gram negatif ou de leurs parois, procede d'obtention d'une telle fraction et medicaments la contenant
JPS536412A (en) * 1976-07-07 1978-01-20 Kureha Chem Ind Co Ltd Preparation of n-containing polysaccharides
FR2388563A1 (fr) * 1977-04-29 1978-11-24 Fabre Sa Pierre Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires

Also Published As

Publication number Publication date
EP0013851B1 (fr) 1982-06-23
PT70610A (fr) 1980-01-01
ZA796661B (en) 1980-11-26
US4397838A (en) 1983-08-09
FR2444464B1 (es) 1982-12-31
AR223690A1 (es) 1981-09-15
JPS6358840B2 (es) 1988-11-17
US4297272A (en) 1981-10-27
AU5344779A (en) 1980-06-26
AU532755B2 (en) 1983-10-13
DE2963201D1 (en) 1982-08-12
ATE1249T1 (de) 1982-07-15
JPS5585525A (en) 1980-06-27
FR2444464A1 (fr) 1980-07-18
MX7557E (es) 1989-10-02
CA1139302A (en) 1983-01-11
EP0013851A1 (fr) 1980-08-06

Similar Documents

Publication Publication Date Title
FR2444464B1 (es)
PT81656B (pt) Processo para a preparacao de polissacarideos bacterianos neutros covalentemente modificados, e de conjugados covalentes estaveis desses polissacarideos e de proteinas imunogenicas
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
EP0171086A3 (en) A method for purification of influenza virus
SE8201348L (sv) Sett att innesluta mikroorganismer fran gruppen mykorrhiza och aktinorhiza
DK22389A (da) Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma
ES2042751T3 (es) Nuevo procedimiento para la purificacion de viriones de la hepatitis a.
NL7416071A (nl) Werkwijze ter bereiding van koolstofvezels.
ATE228391T1 (de) Verbesserte membran
ES8706700A1 (es) Procedimiento para preparar un derivado de cefalosporina.
ES498476A0 (es) Procedimiento de preparacion de arn ribosomales bacterianos
UA19151A (uk) Спосіб одержаhhя оптичhо активhого (+)-4-деметоксидауhоміциhоhу
BG44203A3 (en) Method for preparing of 2- oxyindol- 1- carboxamides
DK23887A (da) Benzimidazolderivater
DK414984A (da) Mono- og bisfunktionelle anthraquinon-(oxy-2,3-oxidopropaner), fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
ES2037003T3 (es) Procedimiento para preparar peptidos empleando percloratos.
ES8200922A1 (es) Procedimiento para preparar kijanimicina
NO150514C (no) Homositronsyre oligoribosid-derivat, fremgangsmaate for dets fremstilling og middel for aa forhindre dental karies
KR790000143B1 (en) Method for preparation of cyanophenyl carbonate
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
BG47345A3 (en) Method for preparing of dialkyloxalacetates
ES2059401T3 (es) Procedimiento microbiologico para la obtencion de una proteina mediante cultivo de una cepa bacteriana mutante.
UA26390A (uk) 5- або 6-заміщеhі складhі ефіри бета-карболіh-3-карбоhової кислоти, які проявляють психотропhу активhість, та фармацевтичhий препарат для лікуваhhя психотропhих захворюваhь
DK632187A (da) Ny forbedret fremgangsmaade til fremstilling af penicillansyrederivater
ES438882A1 (es) Procedimiento para la purificacion de conjugados de protei- na.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000918